SEER, Seer, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for SEER

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask SEER by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(NAUT) Nautilus Biotechnology, Inc


Latest YouTube Video:

Please Login/Register (click on the top-right button) to see the latest video on SEER, Seer, Inc.

CEO:Dr. Omid C. Farokhzad M.D., Ph.D.

Headquarter: 3800 Bridge Parkway, Suite 102, Redwood City, CA, United States, 94065

Industry: Biotechnology,   Employees: 134

Business Summary

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.